Endocyte Offers Preclinical Data for App of SMDC Technology in CAR T Cell Therapy in Late-Breaking Abstract at AACR Meeting
April 19, 2016 at 09:05 AM EDT
Endocyte, Inc. (NASDAQ: ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for ...